Site Members can sign up for company wide alerts
Lawsuit Overview
July 24, 2023 - A consolidated complaint was filed. January 21, 2023 - An investor in shares of Fate Therapeutics, Inc. (NASDAQ: FATE) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Fate Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between April 2, ...
You must register (for free) or login to view the entire case.